Karen Reckamp, MD, MS, is Associate Professor in the Department of Medical Oncology and Therapeutics Research at City of Hope Comprehensive Cancer Center (COHCCC). She received her medical degree from University of Chicago, and her master’s degree in Clinical Investigation from UCLA. She completed residency training in Internal Medicine at Barnes-Jewish Hospital and a Hematology/Oncology fellowship at the David Geffen School of Medicine at UCLA.
Her activities at City of Hope include Director of Clinical Trials, Medical Director of the Thoracic Oncology program and Chair of the COHCCC scientific review committee. She is a member of the National Comprehensive Cancer Network Lung Cancer (NCCN), Thymic Malignancies and Mesothelioma Guidelines Committees. She serves as principal investigator for many Phase I, II and III studies funded by the National Cancer Institute, internal funds, and industry. Dr. Reckamp is a member of ASCO, American Association for Cancer Research (AACR), IASLC, and Southwest Oncology Group (SWOG). She participated in the ASCO Leadership Development Program and led the Scientific Committee for metastatic lung cancer for the ASCO annual meeting. Dr. Reckamp has been the past recipient of many honors including Phase I Clinical Investigator Award in 2006 and ASCO/AACR Methods in Clinical Cancer Research Workshop in 2003. She has also authored or co-authored many manuscripts in the field of Thoracic Oncology.